KEGG   DRUG: Tiragolumab
Entry
D11482                      Drug                                   
Name
Tiragolumab (USAN/INN);
Tiragolumab (genetical recombination) (JAN)
Formula
C6620H10206N1742O2074S40
Exact mass
148571.5530
Mol weight
148662.96
Sequence
(Heavy chain)
EVQLQQSGPG LVKPSQTLSL TCAISGDSVS SNSAAWNWIR QSPSRGLEWL GKTYYRFKWY
SDYAVSVKGR ITINPDTSKN QFSLQLNSVT PEDTAVFYCT RESTTYDLLA GPFDYWGQGT
LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP
AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA
PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP
REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL
PPSREEMTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT
VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK
(Light chain)
DIVMTQSPDS LAVSLGERAT INCKSSQTVL YSSNNKKYLA WYQQKPGQPP NLLIYWASTR
ESGVPDRFSG SGSGTDFTLT ISSLQAEDVA VYYCQQYYST PFTFGPGTKV EIKRTVAAPS
VFIFPPSDEQ LKSGTASVVC LLNNFYPREA KVQWKVDNAL QSGNSQESVT EQDSKDSTYS
LSSTLTLSKA DYEKHKVYAC EVTHQGLSSP VTKSFNRGEC
(Disulfide bridge: H22-H99, H153-H209, H229-L220, H235-H'235, H238-H'238, H270-H330, H376-H434, H'22-H'99, H'153-H'209, H'229-L'220, H'270-H'330, H'376-H'434, L23-L94, L140-L200, L'23-L'94, L'140-L'200)
  Type
Peptide
Class
Antineoplastic
 DG02938  Immune checkpoint inhibitor
Efficacy
Antineoplastic, Immune checkpoint inhibitor, Anti-TIGIT receptor antibody
  Type
Monoclonal antibody
Target
TIGIT [HSA:201633] [KO:K16350]
  Pathway
hsa04514  Cell adhesion molecule (CAM) interaction
Brite
Drug groups [BR:br08330]
 Antineoplastic
  DG02938  Immune checkpoint inhibitor
   D11482  Tiragolumab
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Other cell surface molecules
   Immune checkpoints
    TIGIT
     D11482  Tiragolumab (USAN/INN)
Other DBs
CAS: 1918185-84-8
PubChem: 384585458
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system